These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2542692)

  • 1. Glucocorticoids stimulate the release of a viral tumor marker (MMTV gp52) while inhibiting tumor cell growth.
    Ritzi EM; Walthall EB
    J Steroid Biochem; 1989 Apr; 32(4):499-505. PubMed ID: 2542692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of mouse mammary tumor virus envelope glycoprotein (Gp52) by growth factors.
    Ritzi EM; Walthall EB
    Intervirology; 1988; 29(3):144-53. PubMed ID: 2846465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative flow cytometry reveals a hierarchy of glucocorticoid effect on cell surface mouse mammary tumor virus gp52.
    Ritzi EM
    J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):33-42. PubMed ID: 8645615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shedding of virus-free MMTV gp52 by nonproducer mammary tumor cells: a source of tumor marker in the presence and absence of dexamethasone.
    Ritzi EM; Walthall EB
    Intervirology; 1989; 30(2):102-10. PubMed ID: 2542180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of mouse mammary tumor virus gp52 abundance by protein A assay: a comparison of viral antigen expression on C3H and GR mammary tumor cells.
    Callis AH; Ritzi EM
    Intervirology; 1981; 15(2):111-20. PubMed ID: 6271704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative flow cytometry of mouse mammary tumor virus envelope glycoprotein (gp52): alternative measures of hormone-mediated change in a viral cell surface antigen.
    Ritzi EM
    J Virol Methods; 1992 Oct; 40(1):11-30. PubMed ID: 1331158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive and negative modification of dexamethasone-mediated MMTV gp52 release by progesterone pretreatment of tumor cells.
    Ritzi EM; Walthall EB
    Intervirology; 1989; 30(2):111-6. PubMed ID: 2542181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of viral antigens released into plasma and culture fluids by murine mammary tumor cells.
    Ritzi EM; Smith BA; Stolfi RL; Martin DS
    Cancer Res; 1981 Oct; 41(10):3885-90. PubMed ID: 6269731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a C3Hf mammary tumor cell line expressing endogenous mouse mammary tumor virus: antigenic and genetic relationships of this virus with highly oncogenic mouse mammary tumor viruses.
    Arthur LO; Lovinger GG; Schochetman G
    J Virol; 1979 Dec; 32(3):852-9. PubMed ID: 92576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipids alter the level and distribution of mouse mammary tumor virus gp52 in vitro.
    Sunzeri FJ; Buehring GC
    Cancer Lett; 1993 Oct; 74(1-2):57-64. PubMed ID: 8287372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice with spontaneous mammary tumors develop type-specific neutralizing and cytotoxic antibodies against the mouse mammary tumor virus envelope protein gp52.
    Schochetman G; Arthur LO; Long CW; Massey RJ
    J Virol; 1979 Oct; 32(1):131-9. PubMed ID: 94356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of viral glycoprotein reflect enhanced effectiveness of combined drug treatments.
    Ritzi EM; Pyo S
    Life Sci; 1994; 54(13):887-99. PubMed ID: 8139377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and characterization of mouse mammary tumor virus cell surface antigens: estimation of antigen abundance by protein A assay.
    Callis AH; Ritzi EM
    J Virol; 1980 Sep; 35(3):876-87. PubMed ID: 6252344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of viral glycoprotein provide a dose-dependent measure of tumor cell inhibition.
    Ritzi EM; Pyo S
    Life Sci; 1989; 44(26):2041-50. PubMed ID: 2545986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and disposition of the murine mammary tumor virus (MuMTV) envelope gene products by murine mammary tumor cells.
    Sarkar NH; Racevskis J
    Virology; 1983 Apr; 126(1):279-300. PubMed ID: 6302986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell culture factors influencing in vitro expression of mouse mammary tumor virus.
    Fine DL; Arthur LO; Young LJ
    In Vitro; 1976 Oct; 12(10):693-701. PubMed ID: 65318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological characterization of mouse mammary tumor virus p10 and its presence in mammary tumors and sera of tumor-bearing mice.
    Arthur LO; Fine DL
    J Virol; 1979 Apr; 30(1):148-56. PubMed ID: 90156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of a viral protein as a diagnostic signal for the presence of tumor : the murine mammary tumor model.
    Ritzi E; Martin DS; Stolfi RL; Spiegelman S
    Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4190-4. PubMed ID: 186789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of endogenous MMTV proviruses in murine mammary cancer induced by chemical carcinogen.
    Knepper JE; Medina D; Butel JS
    Int J Cancer; 1987 Sep; 40(3):414-22. PubMed ID: 3040604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered effects of glucocorticoids on the trafficking and processing of mouse mammary tumor virus glycoproteins constitutively expressed in rat hepatoma cells in the absence of nonglycosylated viral components.
    Platt EJ; Goodman LJ; Kain SR; Zettl KS; Firestone GL
    Mol Endocrinol; 1991 Nov; 5(11):1696-706. PubMed ID: 1664047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.